Category Biology/Biotechnology

Circadian rhythm drives metabolic dysfunction in fat cells, study finds

Joseph Bass, MD, PhD, the Charles F. Kettering Professor of Endocrinology and Metabolism and director of the Center for Diabetes and Metabolism, was senior author of the study published in Nature Metabolism. 

Northwestern Medicine scientists led by Joseph Bass, MD, Ph.D., the Charles F. Kettering Professor of Endocrinology and Metabolism and director of the Center for Diabetes and Metabolism, have discovered how disruptions in the circadian rhythm impair metabolic function in fat cells, providing new insights into the molecular mechanisms that cause obesity and metabolic disease, according to a recent study published in Nature Metabolism.

“It’s not simply the accrual of excess fat that leads to disease...

Read More

Tubulin prevents toxic protein clumps in the brain, fighting back against neurodegeneration

Tubulin prevents toxic protein clumps in the brain, fighting back neurodegeneration
WT Tau/αSyn Endogenous Colocalization in Cells and Tau/αSyn/Tubulin Confocal Phase Diagram. Credit: Nature Communications (2026). DOI: 10.1038/s41467-026-69618-3

Researchers at Baylor College of Medicine have discovered a potential new strategy to fight back against Alzheimer’s and Parkinson’s diseases, conditions that are linked to the toxic accumulation of Tau and alpha synuclein protein clumps in the brain. The team reports in Nature Communications that tubulin, the building block of microtubules, the cell’s internal ‘railway tracks,” can stop Tau and alpha synuclein from forming toxic clumps and instead steer them into their normal, healthy roles.

“Tau and alpha synuclein are well known for their roles in neurodegenerative diseases like Alzheimer’s and Parkinson’s...

Read More

AAOS: GLP-1 receptor agonist use increases five-year risk for osteoporosis

AAOS: GLP-1 receptor agonist use increases five-year risk for osteoporosis

Treatment with glucagon-like peptide-1 receptor agonists (GLP-1 RAs) for type 2 diabetes and obesity is independently associated with a significantly increased five-year risk for osteoporosis, gout, and osteomalacia compared with nonuse, according to a study presented at the annual meeting of the American Academy of Orthopaedic Surgeons, held from March 2 to 6 in New Orleans.

Muaaz Wajahath, from the Michigan State University College of Human Medicine in East Lansing, and colleagues evaluated the five-year risk for osteoporosis, gout, and osteomalacia in adults with both type 2 diabetes and obesity treated with GLP-1 RAs (semaglutide, liraglutide, dulaglutide, or exenatide) compared with matched controls (73,483 per group).

The researchers found that at five years, patients expo...

Read More

Scientists successfully harvest chickpeas from ‘moon dirt’

As the U.S. plans to return to the moon with the upcoming Artemis II mission, a question endures: What will future lunar explorers eat? According to new research from The University of Texas at Austin, the answer might be chickpeas.

Scientists have successfully grown and harvested chickpeas using simulated “moon dirt,” the first instance of this crop produced in this medium. The research, which was conducted in collaboration with Texas A&M University, is described in a paper published in the journal Scientific Reports.

Sara Santos, the principal investigator of the project, said that the work is a giant leap in understanding what it will take to grow food on the lunar surface.

“The research is about understanding the viability of growing crops on the moon,” said Santos, who i...

Read More